Laboratory for Molecular Structure, National Institute for Biological Standards and Control, Herts, EN6 3QG, UK.
Appl Spectrosc. 2021 Jul;75(7):857-866. doi: 10.1177/0003702821992370. Epub 2021 Feb 23.
There is growing interest in the use of algorithms to objectively compare near-UV spectra of protein biopharmaceuticals in a regulated environment. Such use will require that the methods be validated, with International Conference on the Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q2(R1) currently being the key document. A key aspect of such validation is to understand how robust the method is to experimental variation. Noise-free simulated spectra, obtained by fitting multiple Gaussian peaks to experimental data obtained from a pharmaceutical protein, were used to assess the robustness of several algorithms in response to spectral data "imperfections". Sources and magnitudes of these imperfections were derived from published inter-laboratory studies. Spectral noise, wavelength calibration errors, intensity variation, and spectral offset errors were "titrated" into the noise-free simulated spectrum and imperfect data sets were compared with the simulated data using a variety of published algorithms, including Pearson, Prestrelski, and derivative correlation algorithms, and spectral overlap, spectral difference and weighted spectral difference methods, to understand how robust outputs are to imperfect data. Algorithm was assessed by comparing their sensitivity to imperfect data against the pairwise statistical variation between 20 replicate spectra.
人们越来越感兴趣的是在监管环境中使用算法来客观比较蛋白质生物制剂的近紫外光谱。这种使用将需要对方法进行验证,目前,国际人用药品注册技术协调会(ICH)Q2(R1)是关键文件。验证的一个关键方面是要了解该方法对实验变异的稳健性如何。通过将多个高斯峰拟合到从制药蛋白获得的实验数据,获得无噪声模拟光谱,用于评估几种算法对光谱数据“不完美”的响应的稳健性。这些不完美的来源和大小是从已发表的实验室间研究中得出的。光谱噪声、波长校准误差、强度变化和光谱偏移误差被“滴定”到无噪声模拟光谱中,并使用各种已发表的算法(包括 Pearson、Prestrelski 和导数相关算法)以及光谱重叠、光谱差异和加权光谱差异方法将不完美的数据与模拟数据进行比较,以了解输出对不完美数据的稳健性如何。通过比较算法对不完美数据的敏感性与其对 20 个重复光谱之间的成对统计差异的敏感性,对算法进行了评估。